SCOTT HERFEL: Open Payments
NPI 1427082387 · SETAUKET, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,170 in 45 payments from 17 companies in 2025. Trend: 2023 $1,252 · 2024 $732 · 2025 $2,170
Food & beverage: $1,341Consulting: $729Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $729 |
| Janssen Biotech, Inc. | 9 | $484 |
| Ferring Pharmaceuticals Inc. | 6 | $156 |
| Amgen Inc. | 1 | $122 |
| UROGEN PHARMA, INC. | 4 | $99 |
| Myriad Genetic Laboratories, Inc. | 3 | $88 |
| IMMUNITYBIO, INC. | 3 | $81 |
| Telix Pharmaceuticals | 3 | $76 |
| DENTSPLY IH AB | 3 | $71 |
| Laborie Medical Technologies Corp. | 2 | $70 |
Products named: Rivfloza, RYBREVANT, ERLEADA, ADSTILADRIN, UPLIZNA, ANKTIVA, ILLUCCIX, LOFRIC.
Industry payments across NY — which companies pay providers there.
